Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
7.28
-0.06 (-0.82%)
Jun 1, 2026, 1:03 PM EDT - Market open
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $716.71 million as of June 1, 2026. Its market cap has increased by 262.71% in one year.
Market Cap
716.71M
Enterprise Value
362.61M
1-Year Change
262.71%
Ranking
Category
Stock Price
$7.28
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $754.10M to $716.71M, a decrease of -4.96%. That is a compound annual growth rate of -0.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 722.60M | 64.45% |
| Dec 31, 2025 | 439.40M | 174.97% |
| Dec 31, 2024 | 159.80M | 28.97% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
| Jan 26, 2018 | 754.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 783.73M |
| Phathom Pharmaceuticals | 761.73M |
| Relmada Therapeutics | 756.24M |
| Allogene Therapeutics | 748.99M |
| BridgeBio Oncology Therapeutics | 718.56M |
| Replimune Group | 717.97M |
| Alto Neuroscience | 703.51M |
| Tenax Therapeutics | 698.89M |